Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies
Otolaryngol Head Neck Surg
.
2019 Feb;160(2):368.
doi: 10.1177/0194599818813521.
Author
Hanny Al-Samkari
PMID:
30798765
DOI:
10.1177/0194599818813521
No abstract available
Publication types
Letter
Comment
MeSH terms
Angiogenesis Inhibitors
Bevacizumab
Epistaxis
Humans
Telangiectasia, Hereditary Hemorrhagic*
Substances
Angiogenesis Inhibitors
Bevacizumab